Altered Striatal Acetylcholine Dynamics in a Model of Parkinson Disease and L-DOPA-induced Dyskinesia
Sophie C Gregoretti, Karen L. Eskow JaunarajsiD, Mariangela ScarduzioiD
Abstract
LDOPA remains the most effective therapy for Parkinson's disease (PD), yet its chronic use often induces involuntary movements known as L-DOPA-induced dyskinesia (LID). While abnormal cholinergic interneuron (ChI) activity is a hallmark of both PD and LID, emerging evidence suggests that the temporal organization of acetylcholine (ACh) signaling, rather than its overall magnitude, may determine its functional impact. Under physiological conditions, ChIs exhibit intrinsic delta-frequency activity reflected in coordinated, slow oscillations of extracellular ACh, which are thought to organize striatal network function and movement pattering. To determine how dopamine (DA) depletion and L-DOPA treatment reshape these ACh dynamics, we used in vivo GRAB-ACh fiber photometry in the unilateral 6-OHDA mouse model. DA depletion disrupted slow ACh rhythmicity, reducing delta-band regularity while increasing higher-frequency phasic activity. Acute L-DOPA broadly suppressed ACh activity across frequencies, partially normalizing this imbalance, but without restoring slow temporal structure. In addition, chronic L-DOPA treatment, associated with established dyskinesia, further impaired delta-band coordination in the DA-depleted striatum during the ON state, while OFF-state activity retained lesion-associated features. The anti-dyskinetic agent amantadine restored low-frequency temporal structure both before and after L-DOPA exposure. Together, these findings reveal a state-dependent reorganization of striatal ACh dynamics, characterized by a shift from coordinated slow oscillations to irregular phasic activity following DA loss, and a further breakdown of slow temporal organization during dyskinetic states. These results highlight the temporal structure of cholinergic signaling as a critical and underappreciated dimension of striatal function in PD and LID.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 23%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Parkinsonian striatal acetylcholine dynamics are refractory to L-DOPA treatment
Eva V Potjer, Xunhui Wu, … Jones G. Parker·bioRxiv·Nov 6, 2025
- Alterations in the intrinsic properties of striatal cholinergic interneurons after dopamine lesion and chronic L-DOPA
Se Joon Choi, Thong Chi Ma, … Un Jung Kang·eLifePeer-reviewed·Jul 20, 2020
- Dopamine 2 receptor ablation from cholinergic neurons attenuates L-DOPA induced dyskinesias.
Santiago Uribe‐Cano, Lauren B. Malave, Andreas H. Kottmann·Frontiers in Aging NeurosciencePeer-reviewed·May 12, 2026
- M4-mediated cholinergic transmission is reduced in parkinsonian mice and its restoration alleviates motor deficits and levodopa-induced dyskinesia
Beatriz Elizabeth Nielsen, Christopher Ford·Science AdvancesPeer-reviewed·Nov 20, 2024
- Cholinergic Transmission in an Inducible Transgenic Mouse Model of Paroxysmal Dystonia
Mariangela Scarduzio, Karen L. Eskow Jaunarajs, David G. Standaert·bioRxiv·Mar 15, 2024
- The GPCR Smoothened on Cholinergic Interneurons Modulates Dopamine-associated Acetylcholine Dynamics and Affects Learning
Santiago Uribe‐Cano, Andreas H. Kottmann·bioRxiv·Jul 3, 2025